Clinical Trial Update: BAY38-9456 - Pivotal Trial for Diabetes Patient [Phase 3]

View source ↗

Summary

BAY38-9456 has completed a pivotal Phase 3 trial in diabetes patients with erectile dysfunction, sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Erectile Dysfunction

Drugs mentioned

• BAY38-9456

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction, Diabetes Mellitus | Phase 3 | Status: COMPLETED